Medicare Advantage change may lower Part B drug prices

The CMS is waiving an Obama-era guidance that prohibited Medicare Advantage plans from imposing prior authorization requirements on Part B drugs.

Read the full post at Modern Healthcare Breaking News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive